This award honors exceptional provider to the AIUM and to the ultrasound community. Its recipients are extremely active in contributing to the growth and development of medical ultrasound. Harvey L. Nisenbaum, MD, recent past president of the AIUM, received acknowledgement for his important involvement in working with the American Urological Association to build up joint performance and schooling guidelines in urology. These advancements serve as a street map for practices desperate to voluntarily seek accreditation through the AIUM.Postoperative pancreatic fistula is the most common main complication after pancreatectomy, with reported rates between 10 percent and 28 percent. Studies suggest that patients in whom postoperative pancreatic fistula develops have a risk of death that is approximately doubled.3,4 Because of the magnitude of this problem, numerous research have investigated methods for reducing the risk of postoperative pancreatic fistula. Prospective trials analyzing operative technique have recognized multiple methods that are associated with acceptable prices of postoperative pancreatic fistula. However, no single approach has been proven to be excellent across institutions.5-9 Since pancreatic exocrine secretion is the proposed mechanism by which postoperative pancreatic fistula occurs, inhibition of the secretion by way of the somatostatin analogue octreotide has been evaluated in multiple trials.10 The total results of these studies have already been mixed.